First report 19 Jan 2016•Latest report 19 Jan 2016
Recipient record
Reports, concerns and published responses
Private and voluntary organisations · Private limited company. This page brings together reports naming this recipient and response statements clearly connected to concerns raised in those reports.
Reports
1
Naming this recipient
Published responses
100%
Found for named reports
Concerns addressed
1
Across all linked responses
Stated actions
1
Described in responses
Reports over time
Reports over time
Reports naming this recipient by issue year.
Evidence profile
Report topics
Share of this recipient’s reports compared with all other recipients.
100%published responses found
1stated actions described
Topic comparisons are not available in the current evidence snapshot.
Concerns and recipient responses
Statements from Takeda UK Limited linked to the concerns in each report. Select any concern, action or position to view the source wording.
Manchester South
Concerns raised7
Failure to define the terms “prolonged” and “hot” in the hot-bath warning
Failure to reconcile prescribed opiate patches with the patient’s actual possession
Failure to maintain clear and sufficiently detailed electronic clinical notes
Failure to provide a full report of the patient’s care
Provision of potentially dangerous bath-removal advice for exhausted Matrifen patches
Failure to prominently communicate the danger of taking a hot bath whilst wearing the patch
Lack of liaison with the GP Practice over regulation of additional opiate pain-control
Responses linked to these concerns
Each statement is shown once, even when linked to more than one concern.
No linked response statements
No action or position from this recipient is clearly linked to the concerns in this report.